FDA Flags 12 Companies for Illicit Hydroquinone-containing Skin Brighteners

April 21, 2022

The U.S. Food and Drug Administration (FDA) has issued warning letters to 12 companies for selling illicit skin brighteners. The products contain the active drug hydroquinone, rendering them unapproved over-the-counter (OTC) drugs rather than cosmetics—and they do not meet the requirements to be legally sold as OTC drugs.The warning letters highlight that these OTC skin-brightening products are not generally recognized as safe or effective (i.e., not GRASE). In fact, the FDA has received reports of serious side effects including skin rashes, facial swelling and ochronosis (discoloration of skin) from the use of skin-brightening products containing hydroquinone. The FDA advises consumers to not use these products due to the potential harm they could cause.Notably, some manufacturers and distributors have already removed their OTC skin-brightening products from the market; the FDA plans to take action against those continuing to market these potentially harmful and illegal OTC products.Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Marketing Whiz Announces Partnership With Boulevard to Help Med Spas and Wellness Clinics Streamline Operations
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing